Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO study

被引：0
|
作者：
Makoto Naganuma
Shinya Sugimoto
Tomohiro Fukuda
Keiichi Mitsuyama
Taku Kobayashi
Naoki Yoshimura
Hidehisa Ohi
Shinji Tanaka
Akira Andoh
Naoki Ohmiya
Keiichiro Saigusa
Takayuki Yamamoto
Yuichi Morohoshi
Hitoshi Ichikawa
Katsuyoshi Matsuoka
Tadakazu Hisamatsu
Kenji Watanabe
Shinta Mizuno
Takayuki Abe
Yasuo Suzuki
Takanori Kanai
机构：
[1] Keio University School of Medicine,Division of Gastroenterology and Hepatology, Department of Internal Medicine
[2] Kurume University School of Medicine,Division of Gastroenterology, Department of Medicine
[3] Kitasato University Kitasato Institute Hospital,Center for Advanced IBD Research and Treatment
[4] Tokyo Yamate Medical Center,Department of Internal Medicine, Division of IBD
[5] Imamura Hospital,Department of Gastroenterology
[6] Hiroshima University Hospital,Department of Endoscopy and Medicine
[7] Shiga University of Medical Science,Department of Medicine
[8] Fujita Health University School of Medicine,Department of Gastroenterology
[9] Tokyo Saiseikai Central Hospital,Department of Medicine
[10] Yokkaichi Hazu Medical Center,IBD Center
[11] Yokohama Municipal Citizen’s Hospital,Department of Medicine
[12] Tokai University Hachioji Hospital,Department of Gastroenterology
[13] Toho University Sakura Medical Center,Department of Gastroenterology
[14] Toho University Sakura Medical Center,Department of Internal Medicine
[15] Kyorin University School of Medicine,The Third Department of Internal Medicine
[16] Hyogo College of Medicine,Department of Intestinal Inflammation Research
[17] Keio University School of Medicine,Department of Preventive Medicine and Public Health, Biostatistics Unit at Clinical and Translational Research Center
[18] Toho University Sakura Medical Center,Inflammatory Bowel Disease Center
来源：
Journal of Gastroenterology | 2020年 / 55卷
关键词：
Ulcerative colitis; Indigo naturalis; Anti-TNFa treatment; Steroid dependent;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：169 / 180
页数：11
相关论文
共 50 条
  • [1] Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO study
    Naganuma, Makoto
    Sugimoto, Shinya
    Fukuda, Tomohiro
    Mitsuyama, Keiichi
    Kobayashi, Taku
    Yoshimura, Naoki
    Ohi, Hidehisa
    Tanaka, Shinji
    Andoh, Akira
    Ohmiya, Naoki
    Saigusa, Keiichiro
    Yamamoto, Takayuki
    Morohoshi, Yuichi
    Ichikawa, Hitoshi
    Matsuoka, Katsuyoshi
    Hisamatsu, Tadakazu
    Watanabe, Kenji
    Mizuno, Shinta
    Abe, Takayuki
    Suzuki, Yasuo
    Kanai, Takanori
    Naganuma, Makoto
    Sugimoto, Shinya
    Mizuno, Shinta
    Nakazato, Yoshihiro
    Fukuda, Tomohiro
    Teratani, Toshiaki
    Ogata, Haruhiko
    Iwao, Yasushi
    Kanai, Takanori
    Yamasaki, Hiroshi
    Mitsuyama, Keiichi
    Kobayashi, Taku
    Toyonaga, Takahiko
    Nakano, Masaru
    Hibi, Toshifumi
    Yoshimura, Naoki
    Sameshima, Yoichi
    Ohi, Hidehisa
    Hayashi, Ryohei
    Ueno, Yoshitaka
    Tanaka, Shinji
    Bamba, Shigeki
    Andoh, Akira
    Watanabe, Mamoru
    Saigusa, Keiichiro
    Nakazawa, Atsushi
    Morohoshi, Yuichi
    Koike, Yuji
    Imai, Jin
    JOURNAL OF GASTROENTEROLOGY, 2020, 55 (02) : 169 - 180
  • [2] INDIGO NATURALIS IS EFFECTIVE IN TREATMENT-REFRACTORY PATIENTS WITH ULCERATIVE COLITIS: POST-HOC ANALYSIS FROM INDIGO STUDY
    Naganuma, Makoto
    Sugimoto, Shinya
    Mitsuyama, Keiichi
    Kobayashi, Taku
    Matsuoka, Katsuyoshi
    Hisamatsu, Tadakazu
    Watanabe, Kenji
    Abe, Takayuki
    Hibi, Toshifumi
    Suzuki, Yasuo
    Kanai, Takanori
    GASTROENTEROLOGY, 2018, 154 (06) : S380 - S380
  • [3] Treatment-refractory ulcerative colitis responsive to indigo naturalis
    Saiki, Julie P.
    Andreasson, Johan O. L.
    Grimes, Kevin, V
    Frumkin, Lyn R.
    Sanjines, Elvi
    Davidson, Matthew G.
    Park, K. T.
    Limketkai, Berkeley
    BMJ OPEN GASTROENTEROLOGY, 2021, 8 (01):
  • [4] Clinical efficacy and future application of indigo naturalis in the treatment of ulcerative colitis
    Wu, Dianzhen
    Huang, Qi
    Xu, Yingbi
    Cao, Ruiyi
    Yang, Ming
    Xie, Jin
    Zhang, Dingkun
    JOURNAL OF ETHNOPHARMACOLOGY, 2025, 337
  • [5] Clinical outcomes of patients with remitting ulcerative colitis after discontinuation of indigo naturalis
    Fumie Shimada
    Yusuke Yoshimatsu
    Tomohisa Sujino
    Tomohiro Fukuda
    Yasuhiro Aoki
    Yukie Hayashi
    Anna Tojo
    Takaaki Kawaguchi
    Hiroki Kiyohara
    Shinya Sugimoto
    Kosaku Nanki
    Yohei Mikami
    Kentaro Miyamoto
    Kaoru Takabayashi
    Naoki Hosoe
    Motohiko Kato
    Haruhiko Ogata
    Makoto Naganuma
    Takanori Kanai
    Scientific Reports, 14
  • [6] Development of an Indigo Naturalis Suppository for Topical Induction Therapy in Patients with Ulcerative Colitis
    Yoshimatsu, Yusuke
    Naganuma, Makoto
    Sugimoto, Shinya
    Tanemoto, Shun
    Umeda, Satoko
    Fukuda, Tomohiro
    Nomura, Ena
    Yoshida, Kosuke
    Ono, Keiko
    Mutaguchi, Makoto
    Nanki, Kosaku
    Mizuno, Shinta
    Mikami, Yohei
    Fukuhara, Kayoko
    Sujino, Tomohisa
    Takabayashi, Kaoru
    Ogata, Haruhiko
    Iwao, Yasushi
    Kanai, Takanori
    DIGESTION, 2020, 101 (04) : 492 - 498
  • [7] Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis
    Naganuma, Makoto
    Sugimoto, Shinya
    Mitsuyama, Keiichi
    Kobayashi, Taku
    Yoshimura, Naoki
    Ohi, Hidehisa
    Tanaka, Shinji
    Andoh, Akira
    Ohmiya, Naoki
    Saigusa, Keiichiro
    Yamamoto, Takayuki
    Morohoshi, Yuichi
    Ichikawa, Hitoshi
    Matsuoka, Katsuyoshi
    Hisamatsu, Tadakazu
    Watanabe, Kenji
    Mizuno, Shinta
    Suda, Wataru
    Hattori, Masahira
    Fukuda, Shinji
    Hirayama, Akiyoshi
    Abe, Takayuki
    Watanabe, Mamoru
    Hibi, Toshifumi
    Suzuki, Yasuo
    Kanai, Takanori
    Grp, I. N. D. I. G. O. Study
    GASTROENTEROLOGY, 2018, 154 (04) : 935 - 947
  • [8] Clinical outcomes of patients with remitting ulcerative colitis after discontinuation of indigo naturalis
    Shimada, Fumie
    Yoshimatsu, Yusuke
    Sujino, Tomohisa
    Fukuda, Tomohiro
    Aoki, Yasuhiro
    Hayashi, Yukie
    Tojo, Anna
    Kawaguchi, Takaaki
    Kiyohara, Hiroki
    Sugimoto, Shinya
    Nanki, Kosaku
    Mikami, Yohei
    Miyamoto, Kentaro
    Takabayashi, Kaoru
    Hosoe, Naoki
    Kato, Motohiko
    Ogata, Haruhiko
    Naganuma, Makoto
    Kanai, Takanori
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [9] Indigo naturalis as a potential drug in the treatment of ulcerative colitis: a comprehensive review of current evidence
    Hu, Yu
    Chen, Liu-lin
    Ye, Zhen
    Li, Lin-zhen
    Qian, Huan-zhu
    Wu, Ming-quan
    Wang, Juan
    Qin, Kai-hua
    Ye, Qiao-bo
    PHARMACEUTICAL BIOLOGY, 2024, 62 (01) : 818 - 832
  • [10] Adverse events in patients with ulcerative colitis treated with indigo naturalis: a Japanese nationwide survey
    Makoto Naganuma
    Shinya Sugimoto
    Hideo Suzuki
    Yuichi Matsuno
    Toshimitsu Araki
    Hirotaka Shimizu
    Ryohei Hayashi
    Tomohiro Fukuda
    Nobuhiro Nakamoto
    Hideki Iijima
    Shiro Nakamura
    Masaharu Kataoka
    Yuichi Tamura
    Koichiro Tatsumi
    Toshifumi Hibi
    Yasuo Suzuki
    Takanori Kanai
    Journal of Gastroenterology, 2019, 54 : 891 - 896
12345